Author: Department of Surgery

Nathaniel Treister, DMD, DMSc, Stephen Sonis, DMD, DMSc, and Sook-Bin Woo, DMD, MMSc, of the Division of Oral Medicine, were included in Boston magazine’s inaugural “Top Dentists 2017” list.

The three BWH Oral Medicine specialists, all board-certified in oral medicine, were among 381 dentists and dental specialists recognized on the list. Honorees were selected by their peers, with more than 600 dentists in Greater Boston completing the magazine’s online survey during the nomination period.

 

Treister is chief of the Division of Oral Medicine and Dentistry. His primary clinical interests include oral mucosal diseases and oral complications of cancer therapy and, in particular, graft-versus-host disease. As an investigator, he studies oral complications related to cancer therapies, with particular interest in hematopoietic cell transplantation, mucositis and graft-versus-host disease.

 

Sonis, former chief of the division, has clinical interests in oral mucosal diseases and regimen-related toxicities of cancer therapy. He is actively involved in translational and clinical research in the areas of supportive cancer care, radiation injury and genomics.

 

Woo, who is also board-certified in oral pathology, has clinical interests in oral lesions, oral mucosal diseases, cancer therapy and bisphosphonate-associated osteonecrosis (a form of bone disease that affects the jaw).

 

Tari A. King, MD, has been appointed the Anne E. Dyson Associate Professor of Surgery in the Field of Women’s Cancers at Harvard Medical School.

Tari A. King, MD
Associate Chair for Multidisciplinary Oncology, Department of Surgery
Chief, Breast Surgery, Dana-Farber/Brigham and Women’s Cancer Center
Anne E. Dyson Associate Professor of Surgery in the Field of Women’s Cancers, Harvard Medical School

Tari A. King, MD, is the chief of Breast Surgery at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), the associate division chief for Breast Surgery at Brigham and Women’s Hospital (BWH) and an associate professor of surgery at Harvard Medical School. She also directs the efforts of the Breast Cancer Personalized Risk assessment, Education and Prevention (B-PREP) Program at BWH. Dr. King received her medical degree from University of Colorado Health Sciences Center and completed a General Surgery Residency at Ochsner Clinic Foundation Hospital (now Ochsner Medical Center) in New Orleans. She completed both a Surgical Research Fellowship and a Breast Surgery Clinical Fellowship at Memorial Sloan Kettering Cancer Center.

Dr. King leads the clinical, research, and educational activities of the breast surgical service while also maintaining an active clinical practice devoted to the diagnosis and surgical treatment of breast cancer. Her clinical and research efforts focus on improving clinical management strategies for women at high risk of developing breast cancer with a special emphasis on lobular carcinoma in situ. She also has an interest in the role of surgery in Stage IV breast cancer and through the Translational Breast Cancer Research Consortium (TBCRC) she successfully initiated and completed accrual to a multi-center trial addressing this issue.

She has received several awards to support her work on the molecular genetics of lobular carcinoma in situ, including the Society of Surgical Oncology (SSO) Clinical Investigator Award in Breast Cancer Research (2008), a Career Catalyst Award (2009), an Investigator Initiated Research Award (2012) and a leadership grant from the Susan G. Komen for the Cure Foundation (2016). Dr. King currently serves on the Steering Committee for the TBCRC and the NCI Breast Oncology Local Disease Task Force and is the vice chair of the Quality Committee for the SSO.